ViewMind Inc.

ViewMind is a digital health company specializing in cutting-edge solutions for accurate assessment of neurocognitive disorders. ViewMind’s technology relies on ocular digital phenotyping to assess the cognitive status of the patient. ViewMind’s fundamental technology is based on research and development led by Dr. Gerardo Fernandez, ViewMind’s Chief Science Officer and Co-founder. ViewMind developed a technology that phenotypes eye movement responses to visual stimuli and the functioning of specific cognitive domains and related areas of the brain. ViewMind is collaborating with various academic institutions, hospitals, research facilities, key opinion leaders, and pharmaceutical companies to test and iterate on this breakthrough technology. ViewMind is the global leader in precision measurement of ocular movement alterations, a window into brain health. ViewMind has exceptional growth potential, with medical centers, clinics, and elderly care centers rapidly adopting its proprietary technology.